NQ Medical (Cambridge, Mass.) said it raised nearly $1.5 million to fund the machine learning technology it’s developing to detect neuromotor disorders through typing.
The funding came from 27 unnamed investors beginning Nov. 5, according to a document filed with the SEC. NQ is hoping to raise a total of nearly $1.6 million in the equity-and-options round.
NQ Medical is using information from the way our fingers interact with smart devices to detect motor impairment to detect neurodegenerative diseases earlier than other traditional methods. Physicians have access to real-time data from a patient’s personal smart device.
The company’s platform can collect and process data passively throughout the day through different personal devices like laptops, desktops, tablets and smartphones. Clinicians and patients can view and monitor the data collected and share with each other.